MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw.
- DOI
- 10.1007/s00520-024-08687-w
- Published
- 2024 Jul 25
- Container
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00520-024-08687-w,
title = {MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw.},
author = {Yarom N and Van Poznak CH and Epstein JB and Ottaviani G and Matsuda Y and Migliorati C and Elad S},
year = {2024},
journal = {Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer},
doi = {10.1007/s00520-024-08687-w},
url = {https://doi.org/10.1007/s00520-024-08687-w}
}RIS
TY - JOUR TI - MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw. AU - Yarom N AU - Van Poznak CH AU - Epstein JB AU - Ottaviani G AU - Matsuda Y AU - Migliorati C AU - Elad S PY - 2024 JO - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer DO - 10.1007/s00520-024-08687-w UR - https://doi.org/10.1007/s00520-024-08687-w ER -
APA
N, Y., CH, V. P., JB, E., G, O., Y, M., C, M., & S, E. (2024). MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08687-w
Source records
- pubmed · retrieved 2026-09-26T13:26:24.923Z